Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Little Engine who wrote (1549)	6/21/1998 6:06:00 PM
From: Prospector	Read Replies (1) \| Respond to of 5402

Good Job again Engine Alliance Pharm Corp: Raw Materials sorce: Perflourocarbon Chemicals readily available : Modest investment: Oxygent Est Production Cost to Equiv Dose: $40 - $ 50.. Sanguine Corp : Raw Material: Perflourocarbon Chemicals: readily available: Modest investment: PHER-02 Est Production Cost to Equiv Dose: $15 - $30 Prospector (thanks little Engine )

To: Little Engine who wrote (1549)	6/21/1998 6:09:00 PM
From: chirodoc	Read Replies (1) \| Respond to of 5402

<<<<<Without FDA approval, the product could not be used on a widespread basis. ......... The original Fluosol-DA was given to 1500 patients without any deaths or side effects. It was removed from the market, not because it didn't work but because of the problems with the Japanese FDA mentioned above. .........and, luckily for all of us investors, pher-02 is superior to fluosol!! .........and don't forget that we can all make a lot of money while we wait for approval. ........ever heard of ENMD? curtis